| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB5
|
ATP-binding cassette, sub-family B (MDR/TAP), member 5
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABI1
|
abl-interactor 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACKR2
|
atypical chemokine receptor 2
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACSM1
|
acyl-CoA synthetase medium-chain family member 1
|
|
ACTN4
|
actinin, alpha 4
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAM8
|
ADAM metallopeptidase domain 8
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADGRE2
|
adhesion G protein-coupled receptor E2
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADM
|
adrenomedullin
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AIM2
|
absent in melanoma 2
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
ANGPT2
|
angiopoietin 2
|
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle)
|
|
ANKRD30A
|
ankyrin repeat domain 30A
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
ANXA6
|
annexin A6
|
|
ANXA7
|
annexin A7
|
|
APC
|
adenomatous polyposis coli
|
|
APOB
|
apolipoprotein B
|
|
APOE
|
apolipoprotein E
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGAP12
|
Rho GTPase activating protein 12
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
ARHGEF26
|
Rho guanine nucleotide exchange factor (GEF) 26
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARPC5
|
actin related protein 2/3 complex, subunit 5, 16kDa
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ASCL2
|
achaete-scute family bHLH transcription factor 2
|
|
ASPH
|
aspartate beta-hydroxylase
|
|
ATF3
|
activating transcription factor 3
|
|
ATM
|
ATM serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AXIN1
|
axin 1
|
|
AXIN2
|
axin 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
|
|
B4GALT3
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BBC3
|
BCL2 binding component 3
|
|
BCAN
|
brevican
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCAR3
|
breast cancer anti-estrogen resistance 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BRK1
|
BRICK1, SCAR/WAVE actin-nucleating complex subunit
|
|
BSG
|
basigin (Ok blood group)
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C1GALT1
|
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1
|
|
CA12
|
carbonic anhydrase XII
|
|
CA9
|
carbonic anhydrase IX
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALB2
|
calbindin 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALD1
|
caldesmon 1
|
|
CAMK1D
|
calcium/calmodulin-dependent protein kinase ID
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CBX5
|
chromobox homolog 5
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCNE1
|
cyclin E1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD109
|
CD109 molecule
|
|
CD14
|
CD14 molecule
|
|
CD163
|
CD163 molecule
|
|
CD209
|
CD209 molecule
|
|
CD24
|
CD24 molecule
|
|
CD276
|
CD276 molecule
|
|
CD34
|
CD34 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD70
|
CD70 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD81
|
CD81 molecule
|
|
CD82
|
CD82 molecule
|
|
CD83
|
CD83 molecule
|
|
CD9
|
CD9 molecule
|
|
CD99
|
CD99 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH13
|
cadherin 13
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEP63
|
centrosomal protein 63kDa
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CLDN1
|
claudin 1
|
|
CLDN18
|
claudin 18
|
|
CLDN4
|
claudin 4
|
|
CLDN6
|
claudin 6
|
|
CLDN7
|
claudin 7
|
|
CLDN9
|
claudin 9
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CLMB
|
calcimembrin
|
|
CLN6
|
ceroid-lipofuscinosis, neuronal 6, late infantile, variant
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A6
|
collagen, type IV, alpha 6
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRMP1
|
collapsin response mediator protein 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSMD1
|
CUB and Sushi multiple domains 1
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CST3
|
cystatin C
|
|
CST6
|
cystatin E/M
|
|
CSTB
|
cystatin B (stefin B)
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNAL1
|
catenin (cadherin-associated protein), alpha-like 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CTSS
|
cathepsin S
|
|
CTTN
|
cortactin
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DACT1
|
dishevelled-binding antagonist of beta-catenin 1
|
|
DCC
|
DCC netrin 1 receptor
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEK
|
DEK proto-oncogene
|
|
DIAPH3
|
diaphanous-related formin 3
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5
|
|
DMKN
|
dermokine
|
|
DMRT1
|
doublesex and mab-3 related transcription factor 1
|
|
DNM2
|
dynamin 2
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD2
|
dopamine receptor D2
|
|
DRG1
|
developmentally regulated GTP binding protein 1
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSTN
|
destrin (actin depolymerizing factor)
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
E2F1
|
E2F transcription factor 1
|
|
ECM1
|
extracellular matrix protein 1
|
|
EDN1
|
endothelin 1
|
|
EFNA1
|
ephrin-A1
|
|
EFNB1
|
ephrin-B1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELF5
|
E74-like factor 5 (ets domain transcription factor)
|
|
ELN
|
elastin
|
|
EMX2
|
empty spiracles homeobox 2
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
ENG
|
endoglin
|
|
ENO1
|
enolase 1, (alpha)
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPHB2
|
EPH receptor B2
|
|
EPS8
|
epidermal growth factor receptor pathway substrate 8
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
EREG
|
epiregulin
|
|
ESM1
|
endothelial cell-specific molecule 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV4
|
ets variant 4
|
|
ETV5
|
ets variant 5
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F11R
|
F11 receptor
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FANCL
|
Fanconi anemia, complementation group L
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBXO39
|
F-box protein 39
|
|
FBXO8
|
F-box protein 8
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FERMT2
|
fermitin family member 2
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FHL2
|
four and a half LIM domains 2
|
|
FILIP1L
|
filamin A interacting protein 1-like
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FN1
|
fibronectin 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXA1
|
forkhead box A1
|
|
FOXC1
|
forkhead box C1
|
|
FOXD3
|
forkhead box D3
|
|
FOXO3
|
forkhead box O3
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
FPR1
|
formyl peptide receptor 1
|
|
FRAT1
|
frequently rearranged in advanced T-cell lymphomas 1
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GABARAP
|
GABA(A) receptor-associated protein
|
|
GALNT2
|
polypeptide N-acetylgalactosaminyltransferase 2
|
|
GALT
|
galactose-1-phosphate uridylyltransferase
|
|
GATA3
|
GATA binding protein 3
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GGCT
|
gamma-glutamylcyclotransferase
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLG1
|
golgi glycoprotein 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2
|
|
GMPR
|
guanosine monophosphate reductase
|
|
GNAS
|
GNAS complex locus
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRH2
|
gonadotropin-releasing hormone 2
|
|
GPC3
|
glypican 3
|
|
GPC6
|
glypican 6
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPX4
|
glutathione peroxidase 4
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H2AFX
|
H2A histone family, member X
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HBP1
|
HMG-box transcription factor 1
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC6
|
histone deacetylase 6
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HINFP
|
histone H4 transcription factor
|
|
HIPK1
|
homeodomain interacting protein kinase 1
|
|
HK2
|
hexokinase 2
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLX
|
H2.0-like homeobox
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOXB13
|
homeobox B13
|
|
HOXB7
|
homeobox B7
|
|
HOXC10
|
homeobox C10
|
|
HOXD3
|
homeobox D3
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HYAL1
|
hyaluronoglucosaminidase 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM3
|
intercellular adhesion molecule 3
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
|
IFNG
|
interferon, gamma
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL17RA
|
interleukin 17 receptor A
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL22
|
interleukin 22
|
|
IL24
|
interleukin 24
|
|
IL6
|
interleukin 6
|
|
ILK
|
integrin-linked kinase
|
|
INHA
|
inhibin, alpha
|
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INSL4
|
insulin-like 4 (placenta)
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IQSEC1
|
IQ motif and Sec7 domain 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF6
|
interferon regulatory factor 6
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB6
|
integrin, beta 6
|
|
ITGB8
|
integrin, beta 8
|
|
ITIH5
|
inter-alpha-trypsin inhibitor heavy chain family, member 5
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JAG1
|
jagged 1
|
|
JAG2
|
jagged 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA0100
|
KIAA0100
|
|
KIAA1524
|
KIAA1524
|
|
KIF11
|
kinesin family member 11
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF17
|
Kruppel-like factor 17
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK1
|
kallikrein 1
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT15
|
keratin 15, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT7
|
keratin 7, type II
|
|
KRT8
|
keratin 8, type II
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMA3
|
laminin, alpha 3
|
|
LAMA4
|
laminin, alpha 4
|
|
LAMA5
|
laminin, alpha 5
|
|
LAMB1
|
laminin, beta 1
|
|
LAMB3
|
laminin, beta 3
|
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2)
|
|
LAMC2
|
laminin, gamma 2
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
|
LGMN
|
legumain
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIF
|
leukemia inhibitory factor
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LMO4
|
LIM domain only 4
|
|
LMO7
|
LIM domain 7
|
|
LOX
|
lysyl oxidase
|
|
LPAR3
|
lysophosphatidic acid receptor 3
|
|
LPAR5
|
lysophosphatidic acid receptor 5
|
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)
|
|
LRIG2
|
leucine-rich repeats and immunoglobulin-like domains 2
|
|
LYPD3
|
LY6/PLAUR domain containing 3
|
|
LYPD5
|
LY6/PLAUR domain containing 5
|
|
MACC1
|
metastasis associated in colon cancer 1
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAGEA9
|
melanoma antigen family A9
|
|
MALAT1
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
|
|
MALT1
|
MALT1 paracaspase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAST2
|
microtubule associated serine/threonine kinase 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCPH1
|
microcephalin 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
ME1
|
malic enzyme 1, NADP(+)-dependent, cytosolic
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED1
|
mediator complex subunit 1
|
|
MEST
|
mesoderm specific transcript
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIA
|
melanoma inhibitory activity
|
|
MIB1
|
mindbomb E3 ubiquitin protein ligase 1
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIER1
|
mesoderm induction early response 1, transcriptional regulator
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR106B
|
microRNA 106b
|
|
MIR10B
|
microRNA 10b
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR125A
|
microRNA 125a
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR126
|
microRNA 126
|
|
MIR130A
|
microRNA 130a
|
|
MIR130B
|
microRNA 130b
|
|
MIR133A1
|
microRNA 133a-1
|
|
MIR135A1
|
microRNA 135a-1
|
|
MIR145
|
microRNA 145
|
|
MIR148A
|
microRNA 148a
|
|
MIR181B1
|
microRNA 181b-1
|
|
MIR181B2
|
microRNA 181b-2
|
|
MIR182
|
microRNA 182
|
|
MIR185
|
microRNA 185
|
|
MIR187
|
microRNA 187
|
|
MIR193A
|
microRNA 193a
|
|
MIR197
|
microRNA 197
|
|
MIR200A
|
microRNA 200a
|
|
MIR200C
|
microRNA 200c
|
|
MIR203A
|
microRNA 203a
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR218-1
|
microRNA 218-1
|
|
MIR218-2
|
microRNA 218-2
|
|
MIR22
|
microRNA 22
|
|
MIR222
|
microRNA 222
|
|
MIR224
|
microRNA 224
|
|
MIR27B
|
microRNA 27b
|
|
MIR29A
|
microRNA 29a
|
|
MIR302A
|
microRNA 302a
|
|
MIR30C1
|
microRNA 30c-1
|
|
MIR34A
|
microRNA 34a
|
|
MIR429
|
microRNA 429
|
|
MIR486-1
|
microRNA 486-1
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP15
|
matrix metallopeptidase 15 (membrane-inserted)
|
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP26
|
matrix metallopeptidase 26
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPRIP
|
myosin phosphatase Rho interacting protein
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MSH2
|
mutS homolog 2
|
|
MSI1
|
musashi RNA-binding protein 1
|
|
MSLN
|
mesothelin
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTA1
|
metastasis associated 1
|
|
MTA3
|
metastasis associated 1 family, member 3
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTSS1
|
metastasis suppressor 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH10
|
myosin, heavy chain 10, non-muscle
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCAN
|
neurocan
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NDUFS3
|
NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase)
|
|
NEK2
|
NIMA-related kinase 2
|
|
NELL2
|
NEL-like 2 (chicken)
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIB
|
nuclear factor I/B
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGFR
|
nerve growth factor receptor
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOV
|
nephroblastoma overexpressed
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NRG1
|
neuregulin 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTS
|
neurotensin
|
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
NUS1
|
nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
ONECUT1
|
one cut homeobox 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
OTX1
|
orthodenticle homeobox 1
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PAPPA2
|
pappalysin 2
|
|
PARD3
|
par-3 family cell polarity regulator
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARVA
|
parvin, alpha
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK6
|
proprotein convertase subtilisin/kexin type 6
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PDPN
|
podoplanin
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEG3
|
paternally expressed 3
|
|
PFN1
|
profilin 1
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHF8
|
PHD finger protein 8
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIP
|
prolactin-induced protein
|
|
PKP1
|
plakophilin 1
|
|
PKP3
|
plakophilin 3
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLEC
|
plectin
|
|
PLEKHA7
|
pleckstrin homology domain containing, family A member 7
|
|
PLG
|
plasminogen
|
|
PLIN1
|
perilipin 1
|
|
PLXNB1
|
plexin B1
|
|
PLXND1
|
plexin D1
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRDX6
|
peroxiredoxin 6
|
|
PREP
|
prolyl endopeptidase
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKD2
|
protein kinase D2
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRLR
|
prolactin receptor
|
|
PRMT2
|
protein arginine methyltransferase 2
|
|
PRMT7
|
protein arginine methyltransferase 7
|
|
PROM1
|
prominin 1
|
|
PROS1
|
protein S (alpha)
|
|
PRRX1
|
paired related homeobox 1
|
|
PSCA
|
prostate stem cell antigen
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGES3
|
prostaglandin E synthase 3 (cytosolic)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12
|
|
PTPN23
|
protein tyrosine phosphatase, non-receptor type 23
|
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTX3
|
pentraxin 3, long
|
|
PXN
|
paxillin
|
|
PYGO2
|
pygopus family PHD finger 2
|
|
RAB14
|
RAB14, member RAS oncogene family
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAB27B
|
RAB27B, member RAS oncogene family
|
|
RAB31
|
RAB31, member RAS oncogene family
|
|
RAB5A
|
RAB5A, member RAS oncogene family
|
|
RAB8A
|
RAB8A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
|
|
RAD51B
|
RAD51 paralog B
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1
|
|
RBP1
|
retinol binding protein 1, cellular
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RFWD2
|
ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
|
|
RGS22
|
regulator of G-protein signaling 22
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOC
|
ras homolog family member C
|
|
RHOD
|
ras homolog family member D
|
|
RHOG
|
ras homolog family member G
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RLN2
|
relaxin 2
|
|
RND3
|
Rho family GTPase 3
|
|
RNF11
|
ring finger protein 11
|
|
RNF17
|
ring finger protein 17
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPS6KA6
|
ribosomal protein S6 kinase, 90kDa, polypeptide 6
|
|
RPSA
|
ribosomal protein SA
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RSPO1
|
R-spondin 1
|
|
RTKN
|
rhotekin
|
|
RUNDC3B
|
RUN domain containing 3B
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RUVBL1
|
RuvB-like AAA ATPase 1
|
|
RUVBL2
|
RuvB-like AAA ATPase 2
|
|
RYK
|
receptor-like tyrosine kinase
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100P
|
S100 calcium binding protein P
|
|
SATB1
|
SATB homeobox 1
|
|
SCGB3A1
|
secretoglobin, family 3A, member 1
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SDC2
|
syndecan 2
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SEC62
|
SEC62 homolog (S. cerevisiae)
|
|
SEL1L
|
sel-1 suppressor of lin-12-like (C. elegans)
|
|
SELE
|
selectin E
|
|
SEMA3E
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
|
|
SEMA3G
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G
|
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
|
SET
|
SET nuclear proto-oncogene
|
|
SFN
|
stratifin
|
|
SFTPB
|
surfactant protein B
|
|
SFTPC
|
surfactant protein C
|
|
SH3GL3
|
SH3-domain GRB2-like 3
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHOX2
|
short stature homeobox 2
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SIRT2
|
sirtuin 2
|
|
SIX1
|
SIX homeobox 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4
|
|
SLC37A4
|
solute carrier family 37 (glucose-6-phosphate transporter), member 4
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX18
|
SRY (sex determining region Y)-box 18
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPAG9
|
sperm associated antigen 9
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRSF3
|
serine/arginine-rich splicing factor 3
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
|
|
ST6GALNAC2
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
|
STIM1
|
stromal interaction molecule 1
|
|
STIM2
|
stromal interaction molecule 2
|
|
STIP1
|
stress-induced phosphoprotein 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STMN1
|
stathmin 1
|
|
SYK
|
spleen tyrosine kinase
|
|
SYNE1
|
spectrin repeat containing, nuclear envelope 1
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAX1BP3
|
Tax1 (human T-cell leukemia virus type I) binding protein 3
|
|
TBX2
|
T-box 2
|
|
TBX21
|
T-box 21
|
|
TBXAS1
|
thromboxane A synthase 1 (platelet)
|
|
TCEAL7
|
transcription elongation factor A (SII)-like 7
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERC
|
telomerase RNA component
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFF1
|
trefoil factor 1
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TGM2
|
transglutaminase 2
|
|
THBS1
|
thrombospondin 1
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TJP2
|
tight junction protein 2
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
|
TLN2
|
talin 2
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR6
|
toll-like receptor 6
|
|
TLR9
|
toll-like receptor 9
|
|
TM4SF5
|
transmembrane 4 L six family member 5
|
|
TMEM207
|
transmembrane protein 207
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TNS4
|
tensin 4
|
|
TOMM34
|
translocase of outer mitochondrial membrane 34
|
|
TONSL
|
tonsoku-like, DNA repair protein
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TPO
|
thyroid peroxidase
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TPX2
|
TPX2, microtubule-associated
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRIO
|
trio Rho guanine nucleotide exchange factor
|
|
TRIP10
|
thyroid hormone receptor interactor 10
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRO
|
trophinin
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSPO
|
translocator protein (18kDa)
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXLNA
|
taxilin alpha
|
|
TYMP
|
thymidine phosphorylase
|
|
UBD
|
ubiquitin D
|
|
UTS2R
|
urotensin 2 receptor
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VAV2
|
vav 2 guanine nucleotide exchange factor
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VMP1
|
vacuole membrane protein 1
|
|
VSNL1
|
visinin-like 1
|
|
WASF1
|
WAS protein family, member 1
|
|
WASF3
|
WAS protein family, member 3
|
|
WASH1
|
WAS protein family homolog 1
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WDR77
|
WD repeat domain 77
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WISP1
|
WNT1 inducible signaling pathway protein 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT2
|
wingless-type MMTV integration site family member 2
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
YY1
|
YY1 transcription factor
|
|
ZBTB33
|
zinc finger and BTB domain containing 33
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFP36
|
ZFP36 ring finger protein
|
